These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

423 related items for PubMed ID: 18030614

  • 1. In situ levels of oestrogen producing enzymes and its prognostic significance in postmenopausal breast cancer patients.
    Licznerska BE, Wegman PP, Nordenskjöld B, Wingren S.
    Breast Cancer Res Treat; 2008 Nov; 112(1):15-23. PubMed ID: 18030614
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Recent insight on the control of enzymes involved in estrogen formation and transformation in human breast cancer.
    Pasqualini JR, Chetrite GS.
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):221-36. PubMed ID: 15860265
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Aromatase localization in human breast cancer tissues: possible interactions between intratumoral stromal and parenchymal cells.
    Miki Y, Suzuki T, Tazawa C, Yamaguchi Y, Kitada K, Honma S, Moriya T, Hirakawa H, Evans DB, Hayashi S, Ohuchi N, Sasano H.
    Cancer Res; 2007 Apr 15; 67(8):3945-54. PubMed ID: 17440110
    [Abstract] [Full Text] [Related]

  • 7. Aromatase expression in stromal cells of endometrioid endometrial cancer correlates with poor survival.
    Segawa T, Shozu M, Murakami K, Kasai T, Shinohara K, Nomura K, Ohno S, Inoue M.
    Clin Cancer Res; 2005 Mar 15; 11(6):2188-94. PubMed ID: 15788666
    [Abstract] [Full Text] [Related]

  • 8. Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial.
    Pentheroudakis G, Kalogeras KT, Wirtz RM, Grimani I, Zografos G, Gogas H, Stropp U, Pectasides D, Skarlos D, Hennig G, Samantas E, Bafaloukos D, Papakostas P, Kalofonos HP, Pavlidis N, Fountzilas G.
    Breast Cancer Res Treat; 2009 Jul 15; 116(1):131-43. PubMed ID: 18668363
    [Abstract] [Full Text] [Related]

  • 9. High syndecan-1 expression in breast carcinoma is related to an aggressive phenotype and to poorer prognosis.
    Barbareschi M, Maisonneuve P, Aldovini D, Cangi MG, Pecciarini L, Angelo Mauri F, Veronese S, Caffo O, Lucenti A, Palma PD, Galligioni E, Doglioni C.
    Cancer; 2003 Aug 01; 98(3):474-83. PubMed ID: 12879463
    [Abstract] [Full Text] [Related]

  • 10. Selective spatial upregulation of intratumoral stromal aromatase in breast cancer patients: evidence for imbalance of local estrogen metabolism.
    Singer CF, Fink-Retter A, Gschwantler-Kaulich D, Thalhammer T, Hudelist G, Mueller R, Czerwenka K, Kubista E.
    Endocr Relat Cancer; 2006 Dec 01; 13(4):1101-7. PubMed ID: 17158756
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The relationship between the insulin-like growth factor-1 system and the oestrogen metabolising enzymes in breast cancer tissue and its adjacent non-cancerous tissue.
    Chong YM, Colston K, Jiang WG, Sharma AK, Mokbel K.
    Breast Cancer Res Treat; 2006 Oct 01; 99(3):275-88. PubMed ID: 16752221
    [Abstract] [Full Text] [Related]

  • 14. 17beta-hydroxysteroid dehydrogenase 14 affects estradiol levels in breast cancer cells and is a prognostic marker in estrogen receptor-positive breast cancer.
    Jansson AK, Gunnarsson C, Cohen M, Sivik T, Stål O.
    Cancer Res; 2006 Dec 01; 66(23):11471-7. PubMed ID: 17145895
    [Abstract] [Full Text] [Related]

  • 15. Loss of Plexin B1 is highly prognostic in low proliferating ER positive breast cancers--results of a large scale microarray analysis.
    Rody A, Karn T, Ruckhäberle E, Hanker L, Metzler D, Müller V, Solbach C, Ahr A, Gätje R, Holtrich U, Kaufmann M.
    Eur J Cancer; 2009 Feb 01; 45(3):405-13. PubMed ID: 19054665
    [Abstract] [Full Text] [Related]

  • 16. The role of STS and OATP-B mRNA expression in predicting the clinical outcome in human breast cancer.
    Al Sarakbi W, Mokbel R, Salhab M, Jiang WG, Reed MJ, Mokbel K.
    Anticancer Res; 2006 Feb 01; 26(6C):4985-90. PubMed ID: 17214375
    [Abstract] [Full Text] [Related]

  • 17. Tumor-stromal interaction through the estrogen-signaling pathway in human breast cancer.
    Yamaguchi Y, Takei H, Suemasu K, Kobayashi Y, Kurosumi M, Harada N, Hayashi S.
    Cancer Res; 2005 Jun 01; 65(11):4653-62. PubMed ID: 15930283
    [Abstract] [Full Text] [Related]

  • 18. Over expression of aromatase protein is highly related to MMPs levels in human breast carcinomas.
    Di GH, Lu JS, Song CG, Li HC, Shen ZZ, Shao ZM.
    J Exp Clin Cancer Res; 2005 Dec 01; 24(4):601-7. PubMed ID: 16471323
    [Abstract] [Full Text] [Related]

  • 19. A candidate molecular signature associated with tamoxifen failure in primary breast cancer.
    Vendrell JA, Robertson KE, Ravel P, Bray SE, Bajard A, Purdie CA, Nguyen C, Hadad SM, Bieche I, Chabaud S, Bachelot T, Thompson AM, Cohen PA.
    Breast Cancer Res; 2008 Dec 01; 10(5):R88. PubMed ID: 18928543
    [Abstract] [Full Text] [Related]

  • 20. Intratumoral concentration of sex steroids and expression of sex steroid-producing enzymes in ductal carcinoma in situ of human breast.
    Shibuya R, Suzuki T, Miki Y, Yoshida K, Moriya T, Ono K, Akahira J, Ishida T, Hirakawa H, Evans DB, Sasano H.
    Endocr Relat Cancer; 2008 Mar 01; 15(1):113-24. PubMed ID: 18310280
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.